Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Bilal Abid

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
The Lancet. Oncology|January 1, 2022
Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 eraMuhammad Bilal Abid
Journal for Immunotherapy of Cancer|May 1, 2021
Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerationsMuhammad Bilal Abid
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2022
Granulocyte Colony-Stimulating Factor Usage in Recipients of Chimeric Antigen Receptor T-Cell ImmunotherapyMuhammad Bilal Abid
Journal for Immunotherapy of Cancer|April 4, 2019
Could the menagerie of the gut microbiome really cure cancer? Hope or hypeMuhammad Bilal Abid
Gene Therapy|April 15, 2018
The revving up of CARsMuhammad Bilal Abid
Lancet (London, England)|May 29, 2023
The denominator in early phase CAR T-cell trials examining novel target antigensMuhammad Bilal Abid
Blood|July 1, 2017
Cystic splenomegaly: ectopic adenocarcinoma of unknown primaryMuhammad Bilal Abid, Norbert Blesing
Postgraduate Medical Journal|December 4, 2019
Becoming a physician: towards a more robust physician recruitment processMuhammad Bilal Abid, Michael O Frank
The Lancet. Infectious Diseases|December 8, 2022
Climate change and the increased burden of dengue fever in PakistanMuhammad Abbas Abid, Muhammad Bilal Abid
Frontiers in Oncology|August 1, 2020
Commentary: Dietary methionine influences therapy in mouse cancer models and alters human metabolismMuhammad Abbas Abid, Muhammad Bilal Abid
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
The Lancet. Oncology|January 1, 2022
Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 eraMuhammad Bilal Abid
Journal for Immunotherapy of Cancer|May 1, 2021
Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerationsMuhammad Bilal Abid
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2022
Granulocyte Colony-Stimulating Factor Usage in Recipients of Chimeric Antigen Receptor T-Cell ImmunotherapyMuhammad Bilal Abid
Journal for Immunotherapy of Cancer|April 4, 2019
Could the menagerie of the gut microbiome really cure cancer? Hope or hypeMuhammad Bilal Abid
Gene Therapy|April 15, 2018
The revving up of CARsMuhammad Bilal Abid
Lancet (London, England)|May 29, 2023
The denominator in early phase CAR T-cell trials examining novel target antigensMuhammad Bilal Abid
Blood|July 1, 2017
Cystic splenomegaly: ectopic adenocarcinoma of unknown primaryMuhammad Bilal Abid, Norbert Blesing
Postgraduate Medical Journal|December 4, 2019
Becoming a physician: towards a more robust physician recruitment processMuhammad Bilal Abid, Michael O Frank
The Lancet. Infectious Diseases|December 8, 2022
Climate change and the increased burden of dengue fever in PakistanMuhammad Abbas Abid, Muhammad Bilal Abid
Frontiers in Oncology|August 1, 2020
Commentary: Dietary methionine influences therapy in mouse cancer models and alters human metabolismMuhammad Abbas Abid, Muhammad Bilal Abid
Pageof 11